However, for some individuals, particularly those with already limited dietary variety or nutritional concerns, taste alterations can pose challenges to maintaining adequate nutrition
Semaglutide is FDA-approved for both type 2 diabetes (Ozempic, 2017) and chronic weight management (Wegovy, 2021), with extensive Phase 3 clinical trial data including the STEP program and SELECT cardiovascular outcomes trial (PMID: 37952131)
Avoid repeated freeze-thaw cycles, as they can degrade peptides
Quality Indicators Third-party testing provides independent verification of product contents
Per Zevay's own FAQ and Terms of Use, every prescribing decision is made independently by a licensed provider after reviewing your health information, and a prescription is not guaranteed
Consistency within a few hours is ideal, but tirzepatide's 7-day action window is forgiving